SEC Company Response from Generation Bio Co. (GBIO) (CIK 0001733294) — Jan 4, 2021
Generation Bio Co. (GBIO) (CIK 0001733294)
Date: Jan. 4, 2021 · CIK: 0001733294 · Accession: 0001193125-21-000980
AI Filing Summary & Sentiment
File numbers found in text: 333-251872
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request Generation Bio Co. 301 Binney Street Cambridge, MA 02142 January 4, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance, Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Abby Adams Re: Generation Bio Co. Registration Statement on Form S-1 File No. 333-251872 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Generation Bio Co. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-251872), as amended, so that it may become effective at 4:10 p.m. Eastern time on January 6, 2021, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request by telephone call to the staff of the U.S. Securities and Exchange Commission. Please contact Stuart M. Falber of Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Company, at (617) 526-6663, or in his absence, Jeffries Oliver-Li at (617) 526-6786, to provide notice of effectiveness, or if you have any other questions regarding this matter. [Remainder of Page Intentionally Left Blank] Very truly yours, GENERATION BIO CO. By: /s/ Geoff McDonough Name: Geoff McDonough, M.D. Title: President and Chief Executive Officer Signature Page to Acceleration Request